Literature DB >> 1451102

The distribution of the tumour photosensitizers Zn(II)-phthalocyanine and Sn(IV)-etiopurpurin among rabbit plasma proteins.

L Polo1, E Reddi, G M Garbo, A R Morgan, G Jori.   

Abstract

Zn-phthalocyanine (ZnPc) and Sn-etiopurpurin (SnET2) incorporated in unilamellar liposomes or solubilized in a Cremophor-EL emulsion have been incubated in vitro with rabbit plasma or intravenously administered to rabbits. Ultracentrifugation and chromatographic analysis of the plasma showed that ZnPc and SnET2 are mainly released to lipoproteins; within the lipoprotein family, both dyes are preferentially bound by low-density (LDL) and high-density (HDL) lipoproteins. The amount of dye bound with these two lipoprotein classes was related to their relative concentration in the plasma; in most cases a larger amount of photosensitizer was bound to HDL as compared to LDL on a protein concentration basis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1451102     DOI: 10.1016/0304-3835(92)90250-y

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

1.  Higher irradiance and photodynamic therapy for age-related macular degeneration (an AOS thesis).

Authors:  Joan W Miller
Journal:  Trans Am Ophthalmol Soc       Date:  2008

Review 2.  Like a bolt from the blue: phthalocyanines in biomedical optics.

Authors:  Nawal Sekkat; Hubert van den Bergh; Tebello Nyokong; Norbert Lange
Journal:  Molecules       Date:  2011-12-23       Impact factor: 4.411

3.  CGP 55398, a liposomal Ge(IV) phthalocyanine bearing two axially ligated cholesterol moieties: a new potential agent for photodynamic therapy of tumours.

Authors:  A Segalla; C Milanesi; G Jori; H G Capraro; U Isele; K Schieweck
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640

4.  Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines.

Authors:  M Soncin; L Polo; E Reddi; G Jori; M E Kenney; G Cheng; M A Rodgers
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.